151P Baseline circulating tumor DNA (ctDNA) biomarker analysis of patients with human epidermal growth factor receptor 2 (HER2)-overexpressing metastatic non–small cell lung cancer (NSCLC) treated with trastuzumab deruxtecan (T-DXd)
E.F. Smit, Enriqueta Felip(Vall d'Hebron Hospital Universitari), D. Uprety(The Barbara Ann Karmanos Cancer Institute), Misako Nagasaka(University of California, Irvine), Kazuhiko Nakagawa(Kindai University Hospital), Luis Paz‐Ares(Clinica Universidad de Navarra), J. Pacheco(University of Colorado Cancer Center), B.T. Li(Memorial Sloan Kettering Cancer Center), David Planchard(Institut Gustave Roussy), C.S. Baik(University of Washington Medical Center), Yasushi Goto(National Cancer Center Hospital East), Haruyasu Murakami(Shizuoka Cancer Center), Kaline Pereira(Daiichi Sankyo (United States)), Ayumi Taguchi(Daiichi-Sankyo (Japan)), Mikihiko Kogo(Daiichi-Sankyo (Japan)), Yusuke Kuwahara(Daiichi Sankyo (United States)), Mengting Zou(Daiichi Sankyo (United States)), Wentao Feng(Daiichi Sankyo (United States)), Zenta Tsuchihashi(Daiichi Sankyo (United States)), Pasi A. Jänne(Dana-Farber Cancer Institute)
Cited by 1Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis